... Dec 26
BioInvent and Transgene, today announced they have received regulatory approval in Belgium for a clinical trial application (CTA) for a Phase l/lla study of ... Dec 21
Anti-tumor immune memory and iADC platform are showing results ... Oct 27
Oral molecule human trial for treating advance stage tumors with fibroblast starts... Sep 05
RAIN-32 is a potent and selective MDM2 inhibitor that has been evaluated in clinical trials for solid tumors and hematologic malignancies... Sep 03
Northwest Biotherapeutics, a biotechnology company today announced that the Company has acquired Flaskwork... Sep 02
-Advertisements-